Stevens Capital Management’s VivoSim Labs VIVS Stock Holding History

Stevens Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-88	Closed	-$75K	–	1282
2015 Q1	$75K	Buy	+88	New	+$122K	﹤0.01%	936
2014 Q3	–	Sell	-48	Closed	-$96K	–	1298
2014 Q2	$96K	Sell	48 -18	-27%	-$30.2K	﹤0.01%	1005
2014 Q1	$121K	Buy	+66	New	+$153K	﹤0.01%	996

Other funds holding VIVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Stevens Capital Management's VIVS Position: Q2 2015 in Review

Stevens Capital Management sold out of VivoSim Labs (VIVS) in Q2 2015, closing a stake of 88 shares — an estimated $75K sold.

Stevens Capital Management first reported a position in VIVS in Q1 2014 and held it in 3 quarters. The position peaked at $121K in Q1 2014. 120 funds tracked by Wall St. Rank hold VIVS as of Q2 2015.

Stevens Capital Management reported no remaining VivoSim Labs position as of Q2 2015 after selling out during the quarter.
Stevens Capital Management sold 88 VivoSim Labs shares in Q2 2015, an estimated $75K.
Stevens Capital Management first reported a position in VivoSim Labs in Q1 2014 and held it in 3 quarters.
Stevens Capital Management's VivoSim Labs position peaked at $121K in Q1 2014.
120 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2015.

Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.